PMID- 29871220 OWN - NLM STAT- MEDLINE DCOM- 20181009 LR - 20181009 IS - 2096-7993 (Print) IS - 2096-7993 (Linking) VI - 31 IP - 3 DP - 2017 Feb 5 TI - [The expression and clinical significance of RhoA, Ezrin and CD44 in laryngeal squamous cell carcinoma]. PG - 191-194 LID - 10.13201/j.issn.1001-1781.2017.03.006 [doi] AB - Objective:To investigate the expression of RhoA, Ezrin and CD44 proteins in laryngeal squamous cell carcinoma (LSCC), and analyze their roles and mutual relations in invasion and metastasis.Method:The expressions of RhoA, Ezrin and CD44 in 68 specimens of LSCC and 35 specimens of normal laryngeal mucosa tissues were detected by immunohistochemical SABC staining. The results were correlated with clinicopathological parameters.Result:The positive expression rates of RhoA, Ezrin and CD44 in LSCC were 80.9%,82,4% and 70.6%, and the positive expression rates of RhoA, Ezrin and CD44 in normal laryngeal mucosa tissues were 28.5%, 25.7% and 20%, respectively. The expressions of RhoA, Ezrin and CD44 were significantly correlated to depth of invasion (T), lymph node metastasis (N), clinical TNM stage, tumor grade respectively (P< 0.05), but not to age, gender, smoking, tumor location (P> 0.05). The expression of RhoA was positively correlated to that of Ezrin in LSCC, and the expression of Ezrin was positively correlated to that of CD44 in LSCC too (P< 0.05).Conclusion:Our findings suggested that high expressions of RhoA, Ezrin and CD44 might play an important role in the malignant progression of invasion and metastasis of LSCC, which indicated that they might have played synergistic effects in the process. CI - Copyright(c) by the Editorial Department of Journal of Clinical Otorhinolaryngology Head and Neck Surgery. FAU - Xie, Y X AU - Xie YX AD - Hebei North University, Zhangjiakou, 075000, China. FAU - Shang, X L AU - Shang XL AD - Department of Otolaryngology, the First Affiliated Hospital of Hebei North University. FAU - Fan, J AU - Fan J AD - Hebei North University, Zhangjiakou, 075000, China. LA - chi PT - Journal Article PL - China TA - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi JT - Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery JID - 101303164 RN - 0 (CD44 protein, human) RN - 0 (Cytoskeletal Proteins) RN - 0 (Hyaluronan Receptors) RN - 0 (ezrin) RN - 124671-05-2 (RHOA protein, human) RN - EC 3.6.5.2 (rhoA GTP-Binding Protein) SB - IM MH - Carcinoma, Squamous Cell/*metabolism MH - Cytoskeletal Proteins/*metabolism MH - Humans MH - Hyaluronan Receptors/*metabolism MH - Laryngeal Neoplasms/*metabolism MH - Prognosis MH - rhoA GTP-Binding Protein/*metabolism OTO - NOTNLM OT - immunohistochemistry OT - laryngeal neoplasms OT - metastasis COIS- The authors of this article and the planning committee members and staff have no relevant financial relationships with commercial interests to disclose. EDAT- 2017/02/05 00:00 MHDA- 2018/10/10 06:00 CRDT- 2018/06/06 06:00 PHST- 2016/10/07 00:00 [received] PHST- 2018/06/06 06:00 [entrez] PHST- 2017/02/05 00:00 [pubmed] PHST- 2018/10/10 06:00 [medline] AID - 10.13201/j.issn.1001-1781.2017.03.006 [doi] PST - ppublish SO - Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Feb 5;31(3):191-194. doi: 10.13201/j.issn.1001-1781.2017.03.006.